Global In Vitro Diagnostics IVD Quality Control Market Size Is Anticipated To Grow To USD 1.95 Billion By 2035 | CAGR Of 3.9%

Category: Healthcare

RELEASE DATE May 2026
REPORT ID SI19464

The Global In Vitro Diagnostics IVD Quality Control Market Size Is Anticipated To Grow To USD 1.95 Billion By 2035

According to a research report published by Spherical Insights & Consulting, The Global In Vitro Diagnostics IVD Quality Control Market Size Is Estimated To Grow From USD 1.33 Billion In 2025 To USD 1.95 Billion By 2035, At A CAGR Of 3.9% During The Forecast Period 2026-2035.

in-vitro-diagnostics-ivd-quality-control-market

Get more details on this report -

Request Free Sample

 

Browse 210 Market Data Tables And 45 Figures Spread Through 190 Pages and In-Depth TOC On the Global In Vitro Diagnostics IVD Quality Control Market Size, Share, By Type (Quality Controls, Plasma-based Control, Serum-based Control, Whole blood-based Control, Quality Assurance Services, and Others), By Application (Immunochemistry, Haematology, Clinical Chemistry, Alkaline Phosphatase (ALP), and Others), By End User (Hospitals, Laboratories, Home Care, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2026 – 2035.” Get Detailed Report Description Here: https://www.sphericalinsights.com/press-release/in-vitro-diagnostics-ivd-quality-control-market

 

The global in vitro diagnostics (IVD) quality control market refers to the industry that develops products and services that protect laboratories and healthcare centres from any loss of diagnostic test result accuracy and reliability, and consistency. The market experiences growth because chronic diseases and infectious diseases have become more common and people need precise diagnostic tests, and new accredited laboratories have opened and facilities now use automated and molecular diagnostic systems. Governments around the world support the industry through their implementation of regulatory systems and laboratory accreditation programmes and healthcare initiatives which include India's Make in India programme that boosts local medical device production. The main trends that shape the market show increasing demand for third-party quality control solutions and cloud-based QC data management systems and rising adoption of AI diagnostic technologies.

 

The quality controls segment accounted for the largest share in 2025 and is anticipated to grow at a remarkable CAGR during the forecast period.

Based on the type, the global in vitro diagnostics IVD quality control market is divided into quality controls, plasma-based control, serum-based control, whole blood-based control, quality assurance services, and others. Among these, the quality controls segment accounted for the largest share in 2025 and is anticipated to grow at a significant CAGR during the forecast period. This is due to the rising demand for accurate and reliable diagnostic testing, increasing laboratory accreditation requirements, growing adoption of automated diagnostic systems, and the widespread use of routine quality control products across hospitals, diagnostic laboratories, and research institutions worldwide.

 

The clinical chemistry segment accounted for the highest market revenue in 2025 and is anticipated to grow at a significant CAGR during the forecast period.

Based on the application, the global in vitro diagnostics IVD quality control market is divided into immunochemistry, haematology, clinical chemistry, alkaline phosphatase (alp), and others.  Among these, the clinical chemistry segment accounted for the highest market revenue in 2025 and is anticipated to grow at a significant CAGR during the forecast period. This is due to increasing routine blood testing volumes, higher prevalence of chronic diseases, expanding adoption of automated clinical analysers, and strong demand for accurate biochemical diagnostic testing across healthcare facilities worldwide.

 

The laboratories segment dominated the market in 2025 and is projected to grow at a substantial CAGR during the forecast period

Based on the end user, the global in vitro diagnostics IVD quality control market is divided into hospitals, laboratories, home care, and others. Among these, the laboratories segment dominated the market in 2025 and is projected to grow at a substantial CAGR during the forecast period. This is due to the large volume of routine and specialized diagnostic testing in laboratories, increasing regulatory compliance requirements, expanding use of automated diagnostic systems, and growing focus on maintaining accurate, standardized, and reliable diagnostic test results worldwide.

 

North America is expected to hold the majority share of the global in vitro diagnostics IVD quality control market during the forecast period.

in-vitro-diagnostics-ivd-quality-control-market

Get more details on this report -

Request Free Sample

North America is expected to account for the largest share of the global in vitro diagnostics IVD quality control market during the forecast period. This is due to advanced healthcare infrastructure, strong regulatory standards, increasing adoption of automated diagnostic technologies, high healthcare expenditure, and the strong presence of leading diagnostic companies across the region.

The Asia Pacific region is projected to witness the fastest growth, driven by expanding healthcare infrastructure, rising healthcare investments, growing awareness regarding laboratory quality assurance, increasing prevalence of chronic diseases, and rapid adoption of advanced diagnostic and molecular testing technologies in emerging economies such as China and India.

Major vendors in the global in vitro diagnostics IVD quality control market are Bio-Rad Laboratories, Thermo Fisher Scientific Inc, Abbott Laboratories, F. Hoffmann-La Roche Ltd, Siemens Healthineers AG, Danaher Corporation, Sysmex Corporation, QuidelOrtho Corporation, Randox Laboratories Ltd, QIAGEN N.V., Merck KGaA, Hologic Inc, Bio-Techne Corporation, SeraCare Life Sciences Inc, and Others.

 

Key Target Audience

  • Market Players
  • Investors
  • End-users
  • Government Authorities 
  • Consulting and Research Firm
  • Venture capitalists
  • Value-Added Resellers (VARs)

 

Key Market Development

  • In January 2025, Bio-Rad Laboratories launched the Unity Next Peer QC software platform focused on centralized quality control reporting and peer comparison access for laboratories.

 

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the global in vitro diagnostics IVD quality control market based on the below-mentioned segments:

Global In Vitro Diagnostics IVD Quality Control Market, By Type

 

  • Quality Controls
  • Plasma-based Control
  • Serum-based Control
  • Whole blood-based Control
  • Quality Assurance Services
  • Others

 

Global In Vitro Diagnostics IVD Quality Control Market, By Application

  • Immunochemistry
  • Haematology
  • Clinical Chemistry
  • Alkaline Phosphatase (ALP)
  • Others

 

Global In Vitro Diagnostics IVD Quality Control Market, By End User

  • Hospitals
  • Laboratories
  • Home Care
  • Others

 

Global In Vitro Diagnostics IVD Quality Control Market, By Regional Analysis

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • UAE
    • Saudi Arabia
    • Qatar
    • South Africa
    • Rest of the Middle East & Africa

 

About the Spherical Insights & Consulting

Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.

Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements. 

 

CONTACT US:

For More Information on Your Target Market, Please Contact Us Below:    

Phone: +1 303 800 4326 (the U.S.)

Phone: +91 90289 24100 (APAC)

Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com

Contact Us: https://www.sphericalinsights.com/contact-us

Follow Us: LinkedIn | Facebook | Twitter

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies